vs
Side-by-side financial comparison of Broadridge Financial Solutions (BR) and Dexcom (DXCM). Click either name above to swap in a different company.
Broadridge Financial Solutions is the larger business by last-quarter revenue ($1.7B vs $1.3B, roughly 1.4× Dexcom). Dexcom runs the higher net margin — 21.2% vs 16.6%, a 4.6% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs -5.4%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs 10.4%).
Broadridge Financial Solutions, Inc. is a public corporate services and financial technology company. Headquartered in Lake Success, New York, the company was founded in 2007 as a spin-off from Automatic Data Processing. Broadridge supplies companies in the financial industry with financial documents such as proxy statements and annual reports, as well as shareholder communications solutions such as virtual annual meetings.
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
BR vs DXCM — Head-to-Head
Income Statement — Q2 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.7B | $1.3B |
| Net Profit | $284.6M | $267.3M |
| Gross Margin | 27.6% | 62.9% |
| Operating Margin | 12.0% | 25.6% |
| Net Margin | 16.6% | 21.2% |
| Revenue YoY | -5.4% | 21.6% |
| Net Profit YoY | 17.1% | 153.6% |
| EPS (diluted) | $2.42 | $0.67 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $1.3B | ||
| Q4 25 | $1.7B | $1.3B | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | $2.1B | $1.2B | ||
| Q1 25 | $1.8B | $1.0B | ||
| Q4 24 | $1.6B | $1.1B | ||
| Q3 24 | $1.4B | $994.2M | ||
| Q2 24 | $1.9B | $1.0B |
| Q1 26 | — | $267.3M | ||
| Q4 25 | $284.6M | $267.3M | ||
| Q3 25 | — | $283.8M | ||
| Q2 25 | $374.2M | $179.8M | ||
| Q1 25 | $243.1M | $105.4M | ||
| Q4 24 | $142.4M | $151.7M | ||
| Q3 24 | $79.8M | $134.6M | ||
| Q2 24 | $323.2M | $143.5M |
| Q1 26 | — | 62.9% | ||
| Q4 25 | 27.6% | 62.9% | ||
| Q3 25 | — | 60.5% | ||
| Q2 25 | 37.3% | 59.5% | ||
| Q1 25 | 31.8% | 56.9% | ||
| Q4 24 | 27.9% | 58.9% | ||
| Q3 24 | 24.5% | 59.7% | ||
| Q2 24 | 35.5% | 62.4% |
| Q1 26 | — | 25.6% | ||
| Q4 25 | 12.0% | 25.6% | ||
| Q3 25 | — | 20.1% | ||
| Q2 25 | 24.1% | 18.4% | ||
| Q1 25 | 19.0% | 12.9% | ||
| Q4 24 | 13.3% | 17.0% | ||
| Q3 24 | 9.4% | 15.3% | ||
| Q2 24 | 22.7% | 15.7% |
| Q1 26 | — | 21.2% | ||
| Q4 25 | 16.6% | 21.2% | ||
| Q3 25 | — | 23.5% | ||
| Q2 25 | 18.1% | 15.5% | ||
| Q1 25 | 13.4% | 10.2% | ||
| Q4 24 | 9.0% | 13.6% | ||
| Q3 24 | 5.6% | 13.5% | ||
| Q2 24 | 16.6% | 14.3% |
| Q1 26 | — | $0.67 | ||
| Q4 25 | $2.42 | $0.67 | ||
| Q3 25 | — | $0.70 | ||
| Q2 25 | $3.17 | $0.45 | ||
| Q1 25 | $2.05 | $0.27 | ||
| Q4 24 | $1.20 | $0.37 | ||
| Q3 24 | $0.68 | $0.34 | ||
| Q2 24 | $2.72 | $0.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $371.5M | $917.7M |
| Total DebtLower is stronger | $3.2B | — |
| Stockholders' EquityBook value | $2.9B | $2.7B |
| Total Assets | $8.6B | $6.3B |
| Debt / EquityLower = less leverage | 1.10× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $917.7M | ||
| Q4 25 | $371.5M | $917.7M | ||
| Q3 25 | — | $1.8B | ||
| Q2 25 | $562.2M | $1.2B | ||
| Q1 25 | $317.9M | $904.9M | ||
| Q4 24 | $290.6M | $606.1M | ||
| Q3 24 | $293.5M | $621.2M | ||
| Q2 24 | $305.2M | $939.2M |
| Q1 26 | — | — | ||
| Q4 25 | $3.2B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $3.3B | — | ||
| Q1 25 | $3.4B | — | ||
| Q4 24 | $3.7B | — | ||
| Q3 24 | $3.6B | — | ||
| Q2 24 | $3.4B | — |
| Q1 26 | — | $2.7B | ||
| Q4 25 | $2.9B | $2.7B | ||
| Q3 25 | — | $2.7B | ||
| Q2 25 | $2.7B | $2.6B | ||
| Q1 25 | $2.4B | $2.3B | ||
| Q4 24 | $2.2B | $2.1B | ||
| Q3 24 | $2.2B | $2.0B | ||
| Q2 24 | $2.2B | $2.4B |
| Q1 26 | — | $6.3B | ||
| Q4 25 | $8.6B | $6.3B | ||
| Q3 25 | — | $7.5B | ||
| Q2 25 | $8.5B | $7.3B | ||
| Q1 25 | $8.3B | $6.8B | ||
| Q4 24 | $8.2B | $6.5B | ||
| Q3 24 | $8.0B | $6.4B | ||
| Q2 24 | $8.2B | $6.8B |
| Q1 26 | — | — | ||
| Q4 25 | 1.10× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 1.22× | — | ||
| Q1 25 | 1.44× | — | ||
| Q4 24 | 1.64× | — | ||
| Q3 24 | 1.63× | — | ||
| Q2 24 | 1.55× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BR
| Recurring Fee Revenue Investor Communication Solutions | $589.5M | 34% |
| Recurring Fee Revenue Capital Markets | $300.9M | 18% |
| Recurring Fee Revenue Regulatory | $248.7M | 15% |
| Recurring Fee Revenue Customer Communications | $189.2M | 11% |
| Recurring Fee Revenue Wealth And Investment Management | $179.7M | 10% |
| Recurring Fee Revenue Data Driven Fund Solutions | $112.7M | 7% |
| Event Driven Revenue Mutual Funds | $51.4M | 3% |
| Event Driven Revenue Equity And Other | $39.2M | 2% |
| Global Technology And Operations | $7.5M | 0% |
DXCM
Segment breakdown not available.
